We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 515 results
  1. ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis

    Background

    Ankyrin repeat domain 49 (ANKRD49) has been found to be highly expressed in multiple cancer including lung adenocarcinoma (LUAD) and lung...

    Jia Sun, **-rui Hu, ... Min Pang in BMC Cancer
    Article Open access 14 November 2023
  2. Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells

    Methotrexate (MTX) is widely used to treat various diseases. However, it induces adverse reactions like serious lung injury, including pulmonary...

    Masashi Kawami, Takamichi Ojima, ... Mikihisa Takano in Toxicological Research
    Article 16 March 2022
  3. Non B Cell-Derived Immunoglobulins in Lung Epithelial Cells and Lung Cancer

    As the locus for air exchange, lung tissue is perpetually exposed to a significant quantity of foreign pathogens. Consequently, lung has developed a...
    **gshu Tang, Erya Gao, ... Wenwei Shao in Non B cell-Derived Immunoglobulins
    Chapter 2024
  4. Solid dispersion of mebendazole via surfactant carrier to improve oral bioavailability and in vitro anticancer efficacy

    Purpose

    This study aimed to prepare a solid dispersion (SD) formulation of MBZ to improve dissolution and oral bioavailability.

    Methods ...
    Thu Nhan Nguyen, Phuong Tran, ... Jeong-Sook Park in Journal of Pharmaceutical Investigation
    Article 20 March 2023
  5. Pulsatilla saponin D regulates ras-related C3 botulinum toxin substrate 3 (RAC3) to overcome resistance to paclitaxel in lung adenocarcinoma cells

    Background

    Paclitaxel, a tubulin-binding agent, is a Food and Drug Administration-approved first-line drug for the treatment of non-small cell lung...

    Yanyan Lu, Wubin He, ... Xuyang **ao in BMC Cancer
    Article Open access 10 January 2024
  6. Serine synthesis and catabolism in starved lung cancer and primary bronchial epithelial cells

    Serine and glycine give rise to important building blocks in proliferating cells. Both amino acids are either synthesized de novo or taken up from...

    Theresa Haitzmann, Katharina Schindlmaier, ... Katharina Leithner in Cancer & Metabolism
    Article Open access 21 March 2024
  7. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer

    Background

    Extracellular vesicles (EVs) participate in cancer development via cell-to-cell communication. Long non-coding RNAs (lncRNAs), one...

    **nyi Ma, Zhenhua Chen, ... **aodan Meng in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 January 2024
  8. Synthesis and antitumor activity of novel silibinin and 2,3-dehydrosilybin derivatives with carbamate groups

    A novel series of silibinin and 2,3-dehydrosilybin derivatives bearing carbamate groups were designed, synthesized and their in vitro anticancer...

    Qiuchan Wu, Jiang Zeng, **fu Dong in Medicinal Chemistry Research
    Article 15 February 2022
  9. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial–mesenchymal transition

    Non-small cell lung cancer (NSCLC) is characterized by a high incidence of metastasis and poor survival. As epithelial–mesenchymal transition (EMT)...

    Qiu-di Deng, Xue-** Lei, ... **-yong Yu in Acta Pharmacologica Sinica
    Article Open access 23 April 2021
  10. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m6A modification

    N6-methyladenosine (m 6 A) modification is a prevalent RNA epigenetic modification, which plays a crucial role in tumor progression including...

    Qi-cheng Zhang, Yong-mei Qian, ... Ke Xu in Acta Pharmacologica Sinica
    Article 17 October 2023
  11. CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathways

    Cytochrome b5 reductase 3 (CYB5R3) is involved in various cellular metabolic processes, including fatty acid synthesis and drug metabolism. However,...

    Joo-Young Im, Soo ** Kim, ... Misun Won in Experimental & Molecular Medicine
    Article Open access 22 January 2024
  12. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9

    Lung adenocarcinoma (LUAD) characterized by high metastasis and mortality is the leading subtype of non-small cell lung cancer. Evidence shows that...

    Lu Liang, Wen-yan Xu, ... **-yong Yu in Acta Pharmacologica Sinica
    Article 06 April 2022
  13. m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma

    Background

    Lung adenocarcinoma (LUAD) is a common type of lung cancer with a high risk of metastasis, but the exact molecular mechanisms of metastasis...

    Han Fang, Qi Sun, ... **cheng Song in Molecular Cancer
    Article Open access 23 June 2023
  14. Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals

    Plasticity of phenotypic traits refers to an organism’s ability to change in response to environmental stimuli. As a result, the response may alter...

    Sajad Fakhri, Seyed Zachariah Moradi, ... Anupam Bishayee in Cancer and Metastasis Reviews
    Article 03 January 2024
  15. PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells

    Lung cancer, as the leading cause of cancer related deaths, is one of the main global health challenges. Despite various progresses in diagnostic and...

    Meysam Moghbeli in Cancer Cell International
    Article Open access 10 May 2024
  16. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells

    Chemotherapy is one of the most common therapeutic methods in advanced and metastatic tumors. Cisplatin (CDDP) is considered as one of the main...

    Faezeh Tolue Ghasaban, Amirhosein Maharati, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 25 April 2023
  17. A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells

    Occupational and environmental exposure of various toxins or cigarette smoke causes non-small cell lung carcinoma (NSCLC); a devastating disease with...

    Sarah Zeitlmayr, Ditila Cami, ... Andreas Breit in Archives of Toxicology
    Article Open access 15 September 2023
  18. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

    Background

    Intrinsic fitness costs are likely to have guided the selection of lineage-determining mutations during emergence of variants of...

    Simon Schröder, Anja Richter, ... Christian Drosten in Virology Journal
    Article Open access 08 November 2023
  19. Antitumor effects of erlotinib in combination with berberine in A431 cells

    Background

    First-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as erlotinib, have been shown to target...

    **angdan Cuan, **ngying Yang, ... Jun Sheng in BMC Pharmacology and Toxicology
    Article Open access 11 May 2023
  20. Thyroid Hormones Shape the Fate of Cancer Cells and Antitumor Immune Responses

    The activation of the innate and the adaptive immune responses contributes to the control and eradication of tumors. Natural killer cells and T...
    Helena Andrea Sterle, Florencia Cayrol, Graciela Alicia Cremaschi in Handbook of Cancer and Immunology
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.